Patents by Inventor Eiji TAKITA

Eiji TAKITA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220275353
    Abstract: By linking a peptide tag having the following amino acid sequence to a protein of interest, and then expressing the protein, the protein of interest is efficiently accumulated in a soluble fraction. X(PY)qPZ P represents proline; X represents an amino acid sequence composed of 0 to 5 amino acids independently selected from the group consisting of arginine (R), glycine (G), serine (S), lysine (K), threonine (T), leucine (L), asparagine (N), glutamine (Q), and methionine (M); Y represents an amino acid sequence composed of 1 to 4 amino acids independently selected from the group consisting of R, G; K, T, L, N, Q, and M; q represents an integer of 1 to 10; and Z represents an amino acid sequence composed of 0 to 10 amino acids independently selected from the group consisting of R, G; S K, T, L, N, Q, and M; with the proviso that the amino acid sequence of the peptide tag contains three or more Q('s), M('s), L('s), N('s), and/or T('s) in total.
    Type: Application
    Filed: August 28, 2019
    Publication date: September 1, 2022
    Applicant: IDEMITSU KOSAN CO., LTD.
    Inventors: Kazuyoshi KOIKE, Eiji TAKITA, Takeshi MATSUI
  • Publication number: 20210130404
    Abstract: A peptide comprising the sequence shown below is added as a peptide tag to a useful protein, followed by allowing its expression. Xm(PYn)qPZr In this formula, X, Y, and Z each represent an amino acid residue independently selected from the group consisting of R, G, S, K, T, L, N, Q, and H, with the proviso that at least one Y represents K, L, N, Q, H, or R. m represents an integer of 0 to 5; n represents 1, 2, or 3; q represents an integer of 1 to 10; and r represents an integer of 0 to 10.
    Type: Application
    Filed: September 11, 2020
    Publication date: May 6, 2021
    Applicant: IDEMITSU KOSAN CO., LTD.
    Inventors: Kazuyoshi KOIKE, Eiji TAKITA, Koichi KANEDA
  • Patent number: 10808253
    Abstract: A peptide comprising the sequence shown below is added as a peptide tag to a useful protein, followed by allowing its expression. Xm(PYn)qPZr In this formula, X, Y, and Z each represent an amino acid residue independently selected from the group consisting of R, G, S, K, T, L, N, Q, and H, with the proviso that at least one Y represents K, L, N, Q, H, or R. m represents an integer of 0 to 5; n represents 1, 2, or 3; q represents an integer of 1 to 10; and r represents an integer of 0 to 10.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: October 20, 2020
    Assignee: IDEMITSU KOSAN CO., LTD.
    Inventors: Kazuyoshi Koike, Eiji Takita, Koichi Kaneda
  • Publication number: 20190024094
    Abstract: A peptide comprising the sequence shown below is added as a peptide tag to a useful protein, followed by allowing its expression. Xm(PYn)qPZr In this formula, X, Y, and Z each represent an amino acid residue independently selected from the group consisting of R, G, S, K, T, L, N, Q, and H, with the proviso that at least one Y represents K, L, N, Q, H, or R. m represents an integer of 0 to 5; n represents 1, 2, or 3; q represents an integer of 1 to 10; and r represents an integer of 0 to 10.
    Type: Application
    Filed: December 28, 2016
    Publication date: January 24, 2019
    Applicant: IDEMITSU KOSAN CO., LTD.
    Inventors: Kazuyoshi KOIKE, Eiji TAKITA, Koichi KANEDA
  • Patent number: 9981027
    Abstract: The present invention provides an agent for controlling colibacillosis including a fusion protein comprising a subunit of Shiga toxin and a subunit of Escherichia coli heat-labile toxin.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: May 29, 2018
    Assignees: IDEMITSU KOSAN CO., LTD., NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE
    Inventors: Kazutoshi Sawada, Takeshi Matsui, Eiji Takita, Takashi Hamabata, Toshio Sato
  • Patent number: 9937271
    Abstract: The present invention provides an agent for controlling Escherichia coli diarrhea comprising a Shiga toxin as an active ingredient.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: April 10, 2018
    Assignees: IDEMITSU KOSAN CO., LTD., NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY, HOKUSAN CO., LTD.
    Inventors: Kazutoshi Sawada, Takeshi Matsui, Eiji Takita, Takeshi Matsumura, Akira Ito, Noriko Tabayashi
  • Publication number: 20170173179
    Abstract: The present invention provides an agent for controlling Escherichia coli diarrhea comprising a Shiga toxin as an active ingredient.
    Type: Application
    Filed: November 25, 2014
    Publication date: June 22, 2017
    Applicants: IDEMITSU KOSAN CO., LTD., NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY, HOKUSAN CO. LTD
    Inventors: Kazutoshi SAWADA, Takeshi MATSUI, Eiji TAKITA, Takeshi MATSUMURA, Akira ITO, Noriko TABAYASHI
  • Publication number: 20170028046
    Abstract: The present invention provides an agent for controlling colibacillosis including a fusion protein comprising a subunit of Shiga toxin and a subunit of Escherichia coli heat-labile toxin.
    Type: Application
    Filed: November 25, 2014
    Publication date: February 2, 2017
    Applicants: IDEMITSU KOSAN CO., LTD., NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE
    Inventors: Kazutoshi SAWADA, Takeshi MATSUI, Eiji TAKITA, Takashi HAMABATA, Toshio SATO